Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    District of Columbia was added to the Locations section. The District of Columbia Locations entry and HHS Vulnerability Disclosure were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:21:11.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a note that publications shown are automatically filled from PubMed and may not be about the study. Updated the revision tag from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T18:55:16.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Removed the warning banner about potential data delays due to a lapse in government funding. The banner previously informed users that information on the site may not be up to date and that the agency may not respond until appropriations are enacted.
    Difference
    0.4%
    Check dated 2025-11-17T18:04:53.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and formatting changes on the study details page with no changes to core content like eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:38:32.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:23:52.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T10:11:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.